Swanbio Therapeutics Limited
- Company number
- 10942620
- Status
- Active
- Type
- Private Limited Company
- Incorporated
- 1 Sep 2017
- Nature of business
- Research and experimental development on biotechnology
- Corporate group
- Spur Therapeutics Holdings Limited (4 companies)
Registered office
Previous names
- Avalon Bio Limited (until 24 Oct 2017)
- Avistat Bio Limited (until 8 Dec 2017)
Officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| PARINI, Michael John | Director | 14 Mar 2024 | 31 Jul 2026 |
| BIRCHER III, James Albert | Director | 14 Mar 2024 | |
| SCHNEIDER, Paul Matthew | Director | 14 Mar 2024 |
Control
| Name | Nature of control | Notified | Ceased |
|---|---|---|---|
| Rachel Lynn Salzman | Ownership Of Shares 25 To 50 Percent Voting Rights 25 To 50 Percent |
1 Sep 2017 | 2 Feb 2018 |
| Karen Fran Kozarsky | Ownership Of Shares 25 To 50 Percent Voting Rights 25 To 50 Percent |
1 Sep 2017 | 2 Feb 2018 |
| Florian Sebald Eichler | Ownership Of Shares 25 To 50 Percent Voting Rights 25 To 50 Percent |
1 Sep 2017 | 2 Feb 2018 |
| Syncona Limited | Ownership Of Shares 50 To 75 Percent Voting Rights 50 To 75 Percent Right To Appoint And Remove Directors |
2 Feb 2018 | 19 Mar 2024 |
| Spur Therapeutics Holdings Limited | Ownership Of Shares 75 To 100 Percent Voting Rights 25 To 50 Percent Right To Appoint And Remove Directors |
19 Mar 2024 |
Accounts
| Year ended | Net assets | Employees |
|---|---|---|
| 31 Dec 2024 | - | - |
| 30 Sep 2023 | - | - |
| 30 Sep 2022 | - | - |
| 30 Sep 2021 | £1,365,849 | 4 |
| 30 Sep 2020 | £9,180,713 | 2 |
| 30 Sep 2019 | £11,363,643 | 2 |
| 30 Sep 2018 | £3,539,269 | - |
Connections
Owned by
Swanbio Therapeutics Limited → Spur Therapeutics Holdings Limited
Directors’ other companies
- BIRCHER III, James Albert - Director at Freeline Therapeutics Holdings Limited
- SCHNEIDER, Paul Matthew - Director at Freeline Therapeutics Holdings Limited
Companies at the same address
- Spur Therapeutics Holdings Limited (15295548)
- Spur Therapeutics Limited (09500073)